Home › NDC Lookup › RxCUI directory › RxCUI 1098498

Brompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution — RxCUI 1098498

Name: Brompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Soluti… (RxCUI 1098498)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1098498 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1098498

Official nameBrompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbrompheniramine maleate 1 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Solution; brompheniramine maleate 1 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Solution

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)711 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brompheniramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It temporarily relieves hay fever symptoms. That means runny nose, sneezing, itching of the nose or throat, and itchy, watery eyes. It treats symptoms for a short time.
The label directs a dose about every 4 hours, but no more than 6 doses in 24 hours. Use only the dosage cup that comes with it, and follow the age-based directions on your bottle....
It might. Drowsiness can happen, so be careful driving or using machinery. Avoid alcohol, sedatives, and tranquilizers because they can make it worse.
No. The label says never to use it to sedate a child or make a child sleepy. Some children get excitable instead of drowsy.

📖 Read our full Brompheniramine guide →

🕸️ Concept Web — How Brompheniramine maleate 0.2 MG/ML / pseudoephedr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Brompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution RxCUI 1098498 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Brompheniramine 1767 IN
- Pseudoephedrine 8896 IN
- Brompheniramine / pseudoephedrine 214326 MIN
- Brompheniramine maleate 142427 PIN
- Pseudoephedrine hydrochloride 91168 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Brompheniramine / pseudoephedrine Oral Solution 371139 SCDF
- Brompheniramine maleate / pseudoephedrine hydrochloride Oral Solution 2645972 SCDFP
- Brompheniramine / pseudoephedrine Oral Liquid Product 1156046 SCDG
- Brompheniramine / pseudoephedrine Oral Product 1156047 SCDG
- Brompheniramine maleate / pseudoephedrine hydrochloride Oral Liquid Product 2661724 SCDGP
- Brompheniramine maleate / pseudoephedrine hydrochloride Oral Product 2661670 SCDGP
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Brompheniramine maleate 0.2 MG/ML 1053257 SCDC
- Pseudoephedrine hydrochloride 3 MG/ML 997015 SCDC

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brompheniramine maleate 0.2 MG/ML SCDC · 1053257
Pseudoephedrine hydrochloride 3 MG/ML SCDC · 997015
Brompheniramine / pseudoephedrine Oral Solution SCDF · 371139
Brompheniramine maleate / pseudoephedrine hydrochloride Oral Solution SCDFP · 2645972
Brompheniramine / pseudoephedrine Oral Liquid Product SCDG · 1156046
Brompheniramine / pseudoephedrine Oral Product SCDG · 1156047
Brompheniramine maleate / pseudoephedrine hydrochloride Oral Liquid Product SCDGP · 2661724
Brompheniramine maleate / pseudoephedrine hydrochloride Oral Product SCDGP · 2661670

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1098498 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00485-0206-16	473 mL in 1 BOTTLE, PLASTIC (0485-0206-16)	RYNEX PSE	EDWARDS PHARMACEUTICALS, INC.	2011-03-07

Observed labelers: EDWARDS PHARMACEUTICALS, INC. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.